PPTA Data Program
In collaboration with industry regulators and stakeholders, PPTA has developed a system that we believe is the best way to present the distribution of core plasma protein therapies in North America. The PPTA Data Program is a voluntary manufacturer initiative undertaken in response to drug shortage concerns, and is intended to provide a reliable, nation-wide assessment of the availability of these life-saving therapies in the United States.
PPTA's Web-based system provides aggregate, monthly distribution data for the following categories of plasma protein therapies:
1. Albumin 5%
2. Albumin 25%
3. Immune Globulin (IG)
4. Plasma-Derived Factor VIII
5. Recombinant Factor VIII
The charts can be accessed by clicking on the link to the product category of your choice. Each chart shows a 12 month snapshot consisting of two lines: one plotting the data points for the monthly distribution volume and another to show the data points for the previous 12 month average distribution volume on a rolling basis.
Highlights from IPPC 2017 +
Mr. Bruno Santoni, Executive Director, PPTA Europe, opened the well-attended IPPC 2017 welcoming the more than 300 attendees to Prague. PPTA thanks its sponsors who help make the IPPC possible. Download the IPPC app for a complete list of sessions and many of the presentations.Read More
PPTA Remembers John W. Walsh +
PPTA is Proud to Support Rare Disease Day 2017 +
The Plasma Protein Therapeutics Association (PPTA) is proud to support Rare Disease Day, an annual international event that seeks to raise awareness about rare diseases and the patients and families that are affected by a rare disease.Read More
PPTA Standards Programs